John An

John An is a seasoned regulatory professional currently serving as the Executive Director at Arrowhead Pharmaceuticals, leading the Clinical Regulatory Strategy Team. With clinical training and extensive experience interacting with various regulatory agencies, John has successfully guided programs from pre-IND to lifecycle management. Previously, they held positions including Executive Director at Sumitomo Pharma America and Director at AbbVie, where they focused on oncology, cardiology, and dermatology. John earned both a Doctor of Pharmacy (PharmD) and a Doctor of Philosophy in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill.